Published on:

Drug Law News

  • Jury selection began this week in a Nevada lawsuit filed against three companies that make or distribute pharmaceuticals by patients who allege they became infected with Hepatitis C through contaminated propofol during colonoscopies.
  • Some lots of Vasopressin Injection are being recalled because they may not be as potent as intended.
  • Some General Electric anesthesia breathing circuits are recalled because they may not allow enough oxygen to reach the patient.
  • There have been major supply problems with Fabrazyme, the only drug approved for a rare genetic disease.
  • Consumers file a class action over a GNC weight-loss drug. (Scroll down.)
  • Who’s to blame for faulty drugs?
  • Should Pfizer be allowed to sell Lipitor over the counter?
  • Johnson & Johnson is reducing its recommended maximum dosage to cut the risk of liver damage.>/li>
  • High doses of Diflucan can lead to birth defects, the FDA says.